Holen Sie sich die Stockscreener-App
5.225
3.25%
0.155
Schlusskurs vom Vortag:
$5.07
Offen:
$5.07
24-Stunden-Volumen:
445.04K
Relative Volume:
0.58
Marktkapitalisierung:
$313.25M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-44.80M
KGV:
-6.9667
EPS:
-0.75
Netto-Cashflow:
$-30.67M
1W Leistung:
+0.10%
1M Leistung:
-8.80%
6M Leistung:
+86.30%
1J Leistung:
-2.33%
1-Tages-Spanne:
$5.04
$5.24
1-Wochen-Bereich:
$4.696
$5.35
52-Wochen-Spanne:
$1.14
$7.20
Aldeyra Therapeutics Inc Stock (ALDX) Company Profile
Firmenname
Aldeyra Therapeutics Inc
Sektor
Branche
Telefon
781-761-4904
Adresse
131 HARTWELL AVENUE, LEXINGTON, MA
Vergleichen Sie ALDX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ALDX
Aldeyra Therapeutics Inc
|
5.23 | 304.43M | 0 | -44.80M | -30.67M | -0.75 |
|
VRTX
Vertex Pharmaceuticals Inc
|
424.27 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
639.86 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
430.38 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
824.41 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.15 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Aldeyra Therapeutics Inc Stock (ALDX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-04-03 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2024-04-02 | Fortgesetzt | H.C. Wainwright | Buy |
| 2022-04-27 | Fortgesetzt | H.C. Wainwright | Buy |
| 2021-02-08 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-12-16 | Eingeleitet | Berenberg | Buy |
| 2020-10-30 | Eingeleitet | Jefferies | Buy |
| 2020-10-16 | Eingeleitet | BTIG Research | Buy |
| 2020-09-22 | Eingeleitet | Alliance Global Partners | Buy |
| 2020-05-12 | Eingeleitet | Oppenheimer | Outperform |
| 2018-12-04 | Eingeleitet | Citigroup | Buy |
| 2018-09-26 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2018-09-13 | Eingeleitet | Janney | Buy |
| 2018-01-26 | Eingeleitet | Seaport Global Securities | Buy |
| 2016-09-26 | Eingeleitet | H.C. Wainwright | Buy |
| 2016-07-01 | Eingeleitet | Stifel | Buy |
| 2015-07-01 | Eingeleitet | Canaccord Genuity | Buy |
| 2015-03-25 | Eingeleitet | Chardan Capital Markets | Buy |
| 2015-03-20 | Bestätigt | H.C. Wainwright | Buy |
| 2014-11-18 | Eingeleitet | H.C. Wainwright | Buy |
| 2014-06-19 | Eingeleitet | Aegis Capital | Buy |
Alle ansehen
Aldeyra Therapeutics Inc Aktie (ALDX) Neueste Nachrichten
Sentiment analysis tools applied to Aldeyra Therapeutics Inc.Weekly Trade Review & Verified Technical Signals - newser.com
Applying Wyckoff theory to Aldeyra Therapeutics Inc. stockWeekly Loss Report & Weekly High Return Stock Forecasts - newser.com
How to interpret RSI for Aldeyra Therapeutics Inc. stockQuarterly Trade Summary & Capital Efficiency Focused Ideas - newser.com
Smart tools for monitoring Aldeyra Therapeutics Inc.’s price actionJuly 2025 Macro Moves & AI Enhanced Trading Signals - newser.com
Can a trend reversal in Aldeyra Therapeutics Inc. lead to recoveryMarket Sentiment Review & Weekly High Conviction Trade Ideas - newser.com
Is Aldeyra Therapeutics Inc. stock resilient to inflationWeekly Market Outlook & Technical Confirmation Trade Alerts - newser.com
How Aldeyra Therapeutics Inc. stock performs in weak economyJuly 2025 Intraday Action & Community Consensus Trade Alerts - newser.com
Intraday pattern recognizer results for Aldeyra Therapeutics Inc.2025 Top Decliners & Growth Focused Stock Reports - newser.com
Live market analysis of Aldeyra Therapeutics Inc.2025 Price Momentum & Short-Term Swing Trade Alerts - newser.com
Analyzing net buyer seller activity in Aldeyra Therapeutics Inc.Insider Buying & AI Enhanced Trading Signals - newser.com
Will Aldeyra Therapeutics Inc. stock split again soonShort Setup & Smart Money Movement Alerts - newser.com
Why Aldeyra Therapeutics Inc. stock could see breakout soonJuly 2025 Market Mood & Breakout Confirmation Alerts - newser.com
Why analysts upgrade Aldeyra Therapeutics Inc. stockJuly 2025 Outlook & Stepwise Entry/Exit Trade Alerts - newser.com
Automated trading signals detected on Aldeyra Therapeutics Inc.Market Trend Review & Free Reliable Trade Execution Plans - newser.com
Combining price and volume data for Aldeyra Therapeutics Inc.Stock Surge & Safe Capital Allocation Plans - newser.com
Is Aldeyra Therapeutics Inc. stock attractive for ETFsIndex Update & Weekly High Momentum Picks - newser.com
Understanding Aldeyra Therapeutics Inc.’s price movementTreasury Yields & Real-Time Stock Entry Alerts - newser.com
Aldeyra Therapeutics Inc.’s volatility index tracking explainedWeekly Trade Analysis & Consistent Growth Stock Picks - newser.com
What insider trading reveals about Aldeyra Therapeutics Inc. stock2025 Momentum Check & High Win Rate Trade Alerts - newser.com
Aldeyra refocuses pipeline on next-gen RASP modulators despite positive phase II success - Indian Pharma Post
Is Aldeyra Therapeutics Inc. stock dividend yield sustainableJuly 2025 Review & AI Enhanced Trade Execution Alerts - newser.com
Catalyst Monitor Outlook, Q4 2025 Report: Pipeline Advances with Key Approvals and Trials: Featuring Cytokinetics's Aficamten, Aldeyra's Reproxalap, GSK's Depemokimab - Yahoo Finance
Evaluating Aldeyra Therapeutics Inc. with trendline analysisWeekly Profit Analysis & Daily Chart Pattern Signal Reports - newser.com
Is Aldeyra Therapeutics Inc. stock affected by interest rate hikesStock Surge & Low Drawdown Momentum Ideas - newser.com
Aldeyra Therapeutics (ALDX) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
Aldeyra’s Experimental Drug Shows Promising Results In Mid-Stage Alcohol Hepatitis Trial - MSN
Aldeyra Cans RASP Asset, Brings Forward Two Others in Pipeline Shakeup - BioSpace
Aldeyra reshuffles pipeline, culling asset despite Phase II success - Yahoo Finance
Finanzdaten der Aldeyra Therapeutics Inc-Aktie (ALDX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.27%
0.05%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):